Health planning National Drug negotiations before the end of October and included in the new rural c foldercure

Health planning: National Drug negotiations before the end of October and included in the new rural cooperative Sohu news recently, the general office of the national health and Family Planning Commission in conjunction with the general office of the Ministry of Finance jointly issued the "notice on a good negotiation drug and the new rural cooperative medical reimbursement policy convergence" (hereinafter referred to as the "notice"), "notice" said. The provinces have not yet adjusted to timely adjust the NCMS reimbursement drug list according to the national drug price negotiations, and strive to negotiate national drugs into the NCMS reimbursement drug list before the end of October 2016. In May 20th this year, the State Planning Commission announced the first batch of national drug price negotiation results to the society, including chronic hepatitis B drug tenofovir first-line treatment of non-small cell lung cancer, targeted therapy of icotinib and gefitinib. Compared with the previous purchase price of public hospitals, 3 kinds of negotiating drug prices fell more than 50%. The first-line treatment of chronic hepatitis B drug tenofovir concern, after negotiations monthly drug costs from 1500 yuan to 490 yuan, the price decline of 67%. According to public information, for the treatment of chronic hepatitis B drug "tenofovir" by the British GlaxoSmithKline Co (GSK) production, the product name is "Tenofovir disoproxil fumarate tablets" brand name "Wei Ruide", the packaging specifications for 300mg× 30 bottles. According to statistics, the disease prevention and control center Chinese as of May 2016, Chinese 90 million hepatitis B virus carriers, including 28 million patients with chronic hepatitis B, 7 million 600 thousand patients with chronic hepatitis C infection, the need for timely correct treatment of antiviral drugs, the drug cost burden of hepatitis B patients heavy. In September 29th, Ministry of human resources and social security issued the "2016 national basic medical insurance, work-related injury insurance and maternity insurance drug list adjustment program (Draft)", which revealed that 3 kinds of drugs, the first batch of national drug price negotiations involved, is expected to list before the end of the year after the completion of adjustment into the health insurance. Subsequently, eFriendsNet charity charity had hepatitis B in October 9th sent by more than 300 signatures in patients with hepatitis B the letter sent to the Ministry of human resources and social security, called for as soon as possible to tenofovir included in health insurance. In October 14th, in that country especially negotiate drug tenofovir will be included in the new rural cooperative medical reimbursement before the end of October, eFriendsNet charity organization volunteers Pan Longfei on surging news () said, this is good news for the majority of hepatitis B patients. "Tenofovir basically does not produce drug dependence and side effects, is very important for the treatment of hepatitis B. Included in Medicare reimbursement, can reduce the economic burden of patients with hepatitis B friends, is a gospel." Pan Longfei said. However, Pan Longfei also pointed out that, in addition to the NCMS, currently tenofovir in some provinces are not included in the Medicare reimbursement list, prices did not fall, resulting in some patients to buy medicine provinces. "We once again called for the implementation as soon as possible, more benefits for some patients with hepatitis b." Pan Longfei said.相关的主题文章: